ITEM 3.01 NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.

On October 1, 2009, Urologix, Inc. (the "Company") received a letter from The Nasdaq Stock Market approving the Company's application to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market. The Company's common stock will be transferred to The Nasdaq Capital Market at the opening of business on October 5, 2009 and will continue to be traded under the symbol "ULGX." The Company issued a press release relating to the transfer to The Nasdaq Capital Market on October 2, 2009, which is attached hereto as Exhibit 99.1.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

Exhibit
No. Description
99.1 Press Release issued on October 2, 2009.

---